Camber debuts generic SamscaGeneric Samsca is used to treat hyponatremia, low levels of sodium in your blood, in people with heart failure and certain hormonal imbalances. AAM report: Generics, biosimilars generated $373B savings in 2021The Association for Accessible Medicines has released its 2022 U.S. Generic & Biosimilar Medicines Savings report highlighting the value of generic and biosimilar medicines. Patient-centered services is one way to improve health outcomes Nicholas Turos, vice president of business development at Babson Diagnostics, discusses making blood testing more convenient and accessible. DSN webinar explores how pharmacists can navigate Test to Treat programs The webinar featured a discussion on how pharmacies can successfully execute a program. U.S. District Court rules in favor of Merck in sitagliptin phosphate patent lawsuit Sitagliptin is an active ingredient in Januvia, Janumet and Janumet XR. Akorn to pay $7.9M to resolve allegations of fraudulent billing Akorn caused Medicare Part D to pay for three Akorn generic drugs that were no longer eligible for Medicare coverage. Novartis to petition U.S. Supreme Court to uphold validity of Gilenya dosing regimen patent Novartis said that it intends to vigorously defend the validity of the patent and is considering all available options. Coherus BioSciences to launch Lucentis biosimilar Cimerli is the first and only FDA-approved biosimilar interchangeable with Lucentis (ranibizumab injection). AllianceRx Walgreens Pharmacy reduces annual patient prescription costs by $6M Clinical audit programs prevent waste, improve adherence, reduce spend and provide outcomes data, the company said. Hikma intros 2 injectables The company is offering bortezomib for injection 3.5 mg and ulvestrant injection 250 mg/5 ml. First Previous 130 131 132 133 134 Next Last
